Questcor Pharma Revenue, Profits - QCOR Annual Income Statement

Add to My Stocks
$93.6 $1.52 (1.65%) QCOR stock closing price Aug 14, 2014 (Closing)

Looking at financial statements, along with the Questcor Pharma stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. The income statement is a summary of the revenue or sales, expenses and profitability - shown as Net Income, or lack of it. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has grown from 509.29M to 798.92M and how operating and non operating activities have impacted the QCOR stock. Along with Questcor Pharma assets and Questcor Pharma free cash flow, Questcor Pharma profits as shown in profit and loss statement give key insights about the business. The net profit for 2013 is $292.6M and the 2013 revenue is $798.92M.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201320122011201020092008
Questcor Pharma Revenues or Net Sales
798.92M509.29M218.16M115.13M88.32M95.24M
Cost Of Goods Sold (COGS)74.36M28.55M12.45M8.01M7.01M7.3M
Questcor Pharma Gross Profit
724.56M480.73M205.71M107.11M81.3M87.94M
Research & Development Expense59.73M34.26M16.77M10.93M9.65M10.61M
Selling General & Admin Expense220.22M147.73M74.47M41.79M29.95M19.24M
Income Before Depreciation Depletion Amortization444.61M298.73M114.46M54.38M41.7M58.08M
Depreciation Depletion Amortization4.77M2.2M1.34M---
Non Operating Income-0.29M----1.15M
Interest Expense------
Questcor Pharma Pretax Income
439.54M297.23M113.74M54.37M42.13M58.73M
Provision for Income Taxes146.93M99.55M34.15M19.3M15.5M18.19M
MinorityInterest------
Investment Gains Losses------
Other Income------
Income Before Extraordinaries & Disc Operations292.6M197.67M79.59M35.07M26.62M40.53M
Extraordinary Items & Discontinued Operations------
Questcor Pharma Profit/ Loss (Net Income)
292.6M197.67M79.59M35.07M26.62M40.53M
Average Shares used to compute Diluted EPS61.45M63.05M66.01M64.74M66.26M71.35M
Average Shares used to compute Basic EPS58.62M60.24M62.5M62.11M64.2M67.76M
Income Before Nonrecurring Items307.93M198.33M79.89M36.34M26.63M36.13M
Income from Nonrecurring Items-15.32M-0.66M-0.3M-1.27M-4.4M
Questcor Pharma Earnings Per Share Basic Net
4.993.281.270.560.410.52
Questcor Pharma Earnings Per Share Diluted Net
4.763.141.210.540.400.49
EPS Diluted Before Nonrecurring Items5.013.151.210.560.400.43
Preferred Dividends Acc Pd------
Dividends Common------
Dividend Per Share Common0.800.400.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Questcor Pharma stock analysis involves checking at least a few of the important things like:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that QCOR stock has a topline or revenue of $798.92M for 2013 as per this Questcor Pharma revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $292.6M for Questcor Pharma for 2013. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called statement of revenue and expense. The QCOR financials along with Questcor Pharma historical stock prices provide a lot of details about the firm.

Annual Income Statements - Questcor Pharmaceuticals Inc Industry Peers

ORION OYJ ADR income statement, United Therapeutics income statement